We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
-0.87%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$369B
AUM Growth
-$12.6B
(-3.3%)
Cap. Flow
+$3.24B
Cap. Flow
% of AUM
0.88%
Top 10 Holdings %
Top 10 Hldgs %
31.8%
Holding
3,300
New
48
Increased
1,756
Reduced
1,134
Closed
76
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$1.25B |
| 2 |
NXUS
Nuveen International Aggregate Bond ETF
NXUS
|
+$938M |
| 3 |
Apple
AAPL
|
+$911M |
| 4 |
Costco
COST
|
+$878M |
| 5 |
NVIDIA
NVDA
|
+$799M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.69B |
| 2 |
ServiceNow
NOW
|
+$651M |
| 3 |
Applied Materials
AMAT
|
+$563M |
| 4 |
Visa
V
|
+$536M |
| 5 |
Carnival Corporation Ltd
CCL
|
+$523M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.9% |
| 2 | Financials | 11.41% |
| 3 | Consumer Discretionary | 10.18% |
| 4 | Industrials | 9.65% |
| 5 | Healthcare | 9.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1851
Lionsgate Studios
LION
$3.88B
| $5.05M | ﹤0.01% |
526,163
-122,204
| -19% | -$1.13M |
|
1852
Asana
ASAN
$1.58B
| $5.03M | ﹤0.01% |
786,633
+11,041
| +1% | +$97.2K |
|
1853
Genco Shipping & Trading
GNK
$1.17B
| $5.03M | ﹤0.01% |
223,226
+159,216
| +249% | +$3.41M |
|
1854
OppFi
OPFI
$770M
| $5.03M | ﹤0.01% |
652,596
-101,443
| -13% | -$929K |
|
1855
Telus
TU
$16B
| $5.01M | ﹤0.01% |
391,380
| – | – |
|
1856
BancFirst
BANF
$3.92B
| $5.01M | ﹤0.01% |
46,149
+283
| +0.6% | +$31.4K |
|
1857
LeMaitre Vascular
LMAT
$2.18B
| $4.98M | ﹤0.01% |
45,578
+790
| +2% | +$75.3K |
|
|
PCG.PRX
1858
PG&E Corp 6.000% Series A Preferred Stock
PCG.PRX
$1.4B
| $4.96M | ﹤0.01% |
115,450
-99,850
| -46% | -$4.25M |
|
1859
Capricor Therapeutics
CAPR
$1.14B
| $4.95M | ﹤0.01% |
162,906
+71,955
| +79% | +$1.92M |
|
1860
Procept Biorobotics
PRCT
$950M
| $4.95M | ﹤0.01% |
197,766
-84,516
| -30% | -$2.38M |
|
1861
WillScot Mobile Mini Holdings
WSC
$4.8B
| $4.93M | ﹤0.01% |
283,972
-73,905
| -21% | -$1.51M |
|
1862
Expro Ltd
XPRO
$1.79B
| $4.93M | ﹤0.01% |
283,004
-18,338
| -6% | -$301K |
|
1863
Walker & Dunlop
WD
$1.65B
| $4.92M | ﹤0.01% |
110,849
-3,612
| -3% | -$204K |
|
|
RZLV
1864
Rezolve AI
RZLV
$893M
| $4.91M | ﹤0.01% |
1,916,391
+1,188,199
| +163% | +$3.35M |
|
1865
Intrepid Potash
IPI
$460M
| $4.88M | ﹤0.01% |
114,209
+85
| +0.1% | +$3.06K |
|
1866
Editas Medicine
EDIT
$399M
| $4.88M | ﹤0.01% |
1,977,509
+609
| +0% | +$1.29K |
|
1867
Avis
CAR
$5.63B
| $4.88M | ﹤0.01% |
33,482
-967
| -3% | -$110K |
|
1868
Regenxbio
RGNX
$623M
| $4.88M | ﹤0.01% |
582,016
-76,494
| -12% | -$804K |
|
1869
Freedom Holding
FRHC
$9.61B
| $4.88M | ﹤0.01% |
33,662
+236
| +0.7% | +$30.2K |
|
|
KW
1870
DELISTED
Kennedy-Wilson Holdings
KW
| $4.87M | ﹤0.01% |
450,404
-1,057,660
| -70% | -$11M |
|
1871
Levi Strauss
LEVI
$9.44B
| $4.87M | ﹤0.01% |
263,239
+1,833
| +0.7% | +$37.6K |
|
1872
Tronox
TROX
$995M
| $4.84M | ﹤0.01% |
495,495
-51,633
| -9% | -$358K |
|
1873
GCM Grosvenor
GCMG
$737M
| $4.84M | ﹤0.01% |
493,848
-8,302
| -2% | -$92K |
|
1874
Upstart Holdings
UPST
$2.58B
| $4.83M | ﹤0.01% |
188,344
-1,288
| -0.7% | -$45.3K |
|
1875
UFP Technologies
UFPT
$1.84B
| $4.83M | ﹤0.01% |
24,935
-79
| -0.3% | -$18.3K |
|
Similar funds
VFT
Nuveen's Q1 2026 Portfolio in Review
As of Q1 2026, Nuveen held 3,300 positions worth $369B, down 3.3% from $382B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Trading was light in Q1 2026: portfolio turnover was 3.8%. Nuveen opened 48 new positions and exited 76, leaving the 3,300-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 33% a quarter earlier, followed by Financials and Consumer Discretionary.
- Nuveen's largest Q1 2026 buy was Sunbelt Rentals Holdings: 2,483,995 shares worth $156M.
- Nuveen added most to AstraZeneca in Q1 2026, an estimated $1.25B increase.
- Nuveen's biggest Q1 2026 reduction was Microsoft, cutting an estimated $1.69B.
- Nuveen fully exited Exact Sciences in Q1 2026, selling an estimated $82.6M.
- Nuveen's ten largest holdings make up 32% of its $369B portfolio in Q1 2026.
- Nuveen opened 48 new positions and closed 76 in Q1 2026.
- Nuveen's portfolio value fell 3.3% quarter-over-quarter to $369B.
Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.